Saturday, March 18, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosurveillance

Spanish Flu-Like Virus with Pandemic Potential Could Emerge

by Global Biodefense Staff
June 13, 2014
Influenza

Emerging bird flu viruses continually threaten to cause pandemics, underscoring the need for better ways to predict potential outbreaks.

A recent study shows that circulating bird flu viruses are very similar to the flu virus that caused the 1918 pandemic—the most devastating disease outbreak ever recorded. Only a few amino acids separate viral proteins currently found in bird populations from proteins in the 1918 virus, suggesting that a similar deadly virus may emerge in the near future.

“Because avian influenza viruses in nature require only a few changes to adapt to humans and cause a pandemic, it is important to understand the mechanisms involved in adaptation and identify the key mutations so we can be better prepared,” says senior study author Yoshihiro Kawaoka of the University of Wisconsin-Madison. “Research findings like this help us assess the risk of outbreaks and could contribute to routine surveillance of influenza viruses.”

The 1918 flu pandemic, known as the Spanish Flu, killed an estimated 50 million people around the world. Today, wild birds harbor a large pool of flu virus genes that may encode proteins with high similarity to the 1918 viral proteins. But, until now, the likelihood that a virus similar to the infamous 1918 virus will emerge and cause a pandemic in the human population had been unclear.

To assess this risk, Kawaoka and his team generated a flu virus composed of eight currently circulating gene segments encoding proteins that resemble the 1918 viral proteins. The resulting 1918-like virus caused flu-like symptoms in ferrets—the best animal model for studying flu virus infection. When the 1918-like virus acquired seven amino acid mutations in a few key proteins, it spread efficiently from animal to animal, suggesting that it has the potential to cause a pandemic.

Moreover, the 1918 viral proteins differed by only a few amino acids from viral proteins that are now circulating in bird populations around the globe, and these subtle differences could be the only thing keeping current viruses from efficiently infecting and spreading among humans. If viruses resembling the 1918 virus acquire a few key mutations to overcome this hurdle, they could potentially cause a pandemic in humans in the near future.

“The worst-case scenario is the emergence of a novel avian influenza virus that exhibits high pathogenicity in humans, like H5N1 viruses, and efficient transmissibility in humans, like seasonal influenza viruses,” Kawaoka says. “Our findings demonstrate the value of continued surveillance of avian influenza viruses and reinforce the need for improved influenza vaccines and antivirals to prepare for such a scenario.”

Read the study at Cell Host & Microbe:  Circulating avian influenza viruses closely related to the 1918 virus have pandemic potential.

Tags: Animal ModelsAntiviralsAvian InfluenzaEmerging ThreatsH5N1InfluenzaPandemic

Related Posts

New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
Why Do Some of the Outbreak Genomes Have More Mutations Than Others?
Biosurveillance

Virginia Institutes Partner to Join National Pathogen Genomics Centers of Excellence Network

October 25, 2022
Researcher holds a pipette
Biodetection

These Nanotech Bubbles Burst When They Detect Viruses in the Air

October 25, 2022
3 large open flasks atop a drip arrangement of filters in a laboratory
Biosurveillance

Study Shows Potential for Wastewater-Based Epidemiology to Monitor Monkeypox

September 9, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC